Clinical Trials Browser

Phase 1 × INDUSTRY × HER2-positive × Clear all

NCT06254807 2024-12-19

CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors

Phase 1 Active not recruiting

HER2-positive